Motoshi Ichikawa

Motoshi Ichikawa

Auto-generated profile, based on publicly available information

Motoshi Ichikawa

Department of Hematology, NTT Medical Center, Tokyo, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2004 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MIMotoshi Ichikawa
Motoshi Ichikawa
TATakashi Asai
Takashi Asai
TSToshiki Saito
Toshiki Saito
GYGo Yamamoto
Go Yamamoto
SSSachiko Seo
Sachiko Seo
MKMineo Kurokawa
Mineo Kurokawa

1 May 2003 in Immunity
Verified
Journal Article
Closed access
TSToshiki Saito
Toshiki Saito
SCShigeru Chiba
Shigeru Chiba
MIMotoshi Ichikawa
Motoshi Ichikawa
AKAtsushi Kunisato
Atsushi Kunisato
TATakashi Asai
Takashi Asai
HHHisamaru Hirai
Hisamaru Hirai

1 August 2008 in Cell Stem Cell
Verified
Journal Article
Closed access
SGSusumu Goyama
Susumu Goyama
GYGo Yamamoto
Go Yamamoto
MSMunetake Shimabe
Munetake Shimabe
TSTomohiko Sato
Tomohiko Sato
MIMotoshi Ichikawa
Motoshi Ichikawa
MKMineo Kurokawa
Mineo Kurokawa

24 April 2013 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
MIMotoshi Ichikawa
Motoshi Ichikawa
Akihide YoshimiAkihide Yoshimi
Akihide Yoshimi
MNMasahiro Nakagawa
Masahiro Nakagawa
NNNahoko Nishimoto
Nahoko Nishimoto
NWNaoko Watanabe-Okochi
Naoko Watanabe-Okochi
MKMineo Kurokawa
Mineo Kurokawa

1 April 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YYYuko Yamaguchi
Yuko Yamaguchi
MKMineo Kurokawa
Mineo Kurokawa
YIYoichi Imai
Yoichi Imai
KIKoji Izutsu
Koji Izutsu
TATakashi Asai
Takashi Asai
HHHisamaru Hirai
Hisamaru Hirai
AML1 (RUNX1) is one of the most frequently disrupted genes in human leukemias. AML1 encodes transcription factors, which play a pivotal role in hematopoietic differentiation, and their inappropriate expression is associated with leukemic transformation of hematopoietic cells. Previous studies demonstrated that the transcription cofactor p300 binds to the C-terminal region of AML1 and stimulates AML1-dependent transcription during myeloid cell differentiation. Here, we report that AML1 is specifically acetylated by p300 in vitro. Mutagenesis analyses reveal that p300 acetylates AML1 at the two conserved lysine residues (Lys-24 and Lys-43). AML1 is subject to acetylation at the same sites in vivo, and p300-mediated acetylation significantly augments the DNA binding activity of AML1. Disruption of these two lysines severely impairs DNA binding of AML1 and reduced the transcriptional activity and the transforming potential of AML1. Taken together, these data indicate that acetylation of AML1 through p300 is a critical manner of posttranslational modification and identify a novel mechanism for regulating the function of AML1.

1 June 2004 in Cell Cycle
Verified
Journal Article
Closed access
MIMotoshi Ichikawa
Motoshi Ichikawa
TATakashi Asai
Takashi Asai
SCShigeru Chiba
Shigeru Chiba
MKMineo Kurokawa
Mineo Kurokawa
SOSeishi Ogawa
Seishi Ogawa
Runx1 (AML-1) is a critical gene involved in human leukemogenesis, originallyidentified at the 21q22 breakpoint of the leukemic translocations of t(8;21)(q21;q22), and is thoughtto be involved in a...